PubRank

Michael E Chernew

Author PubWeight™ 87.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003 3.88
2 The 'Alternative Quality Contract,' based on a global budget, lowered medical spending and improved quality. Health Aff (Millwood) 2012 3.55
3 Performance differences in year 1 of pioneer accountable care organizations. N Engl J Med 2015 2.88
4 Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. JAMA 2007 2.81
5 Delivery system integration and health care spending and quality for Medicare beneficiaries. JAMA Intern Med 2013 2.78
6 Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract. JAMA 2013 2.77
7 Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med 2011 2.76
8 Changes in health care spending and quality 4 years into global payment. N Engl J Med 2014 2.64
9 Unintended consequences of eliminating medicare payments for consultations. JAMA Intern Med 2013 2.21
10 Changes in patients' experiences in Medicare Accountable Care Organizations. N Engl J Med 2014 2.03
11 A hospital system's wellness program linked to health plan enrollment cut hospitalizations but not overall costs. Health Aff (Millwood) 2013 2.02
12 Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 2004 1.86
13 Quality and consumer decision making in the market for health insurance and health care services. Med Care Res Rev 2008 1.66
14 Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? Am J Manag Care 2005 1.55
15 The slowdown in health care spending in 2009-11 reflected factors other than the weak economy and thus may persist. Health Aff (Millwood) 2013 1.54
16 CT angiography is cost-effective for confirmation of internal carotid artery occlusions. J Neuroimaging 2008 1.45
17 The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 2010 1.43
18 The impact of Medicare Part D on hospitalization rates. Health Serv Res 2011 1.43
19 Case management: effects of improved risk and value information. Gerontologist 2003 1.42
20 Medical group responses to global payment: early lessons from the 'Alternative Quality Contract' in Massachusetts. Health Aff (Millwood) 2011 1.32
21 Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation. Circulation 2008 1.25
22 Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med 2008 1.23
23 Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. Am J Manag Care 2006 1.22
24 Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am J Manag Care 2006 1.20
25 Post-acute care and ACOs - who will be accountable? Health Serv Res 2013 1.19
26 Informal caregiving for diabetes and diabetic complications among elderly americans. J Gerontol B Psychol Sci Soc Sci 2002 1.13
27 Chronic illness, treatment choice and workforce participation. Int J Health Care Finance Econ 2003 1.12
28 A new medicare end-of-life benefit for nursing home residents. Health Aff (Millwood) 2010 1.12
29 Applying value-based insurance design to low-value health services. Health Aff (Millwood) 2010 1.11
30 Crowd-out in the State Children's Health Insurance Program (SCHIP): incidence, enrollee characteristics and experiences, and potential impact on New York's SCHIP. Health Serv Res 2008 1.10
31 The sources of the SGR "hole". N Engl J Med 2011 1.08
32 The economics of financing Medicare. N Engl J Med 2011 1.06
33 Value-based insurance design: a "clinically sensitive, fiscally responsible" approach to mitigate the adverse clinical effects of high-deductible consumer-directed health plans. J Gen Intern Med 2007 1.05
34 The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) 2012 1.01
35 The spillover effects of Medicare managed care: Medicare Advantage and hospital utilization. J Health Econ 2013 1.01
36 The impact of the Affordable Care Act on Medicare Advantage plan availability and enrollment. Health Serv Res 2012 0.99
37 Competitive bidding in Medicare: who benefits from competition? Am J Manag Care 2012 0.96
38 Value-based cost sharing in the United States and elsewhere can increase patients' use of high-value goods and services. Health Aff (Millwood) 2013 0.90
39 Value based insurance design: maintaining a focus on health in an era of cost containment. Am J Manag Care 2009 0.90
40 Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation. J Am Coll Cardiol 2008 0.88
41 Global Budgets and Technology-Intensive Medical Services. Healthc (Amst) 2013 0.88
42 Why physicians should like bundled payment. Health Serv Res 2011 0.87
43 Medicaid incentive programs to encourage healthy behavior show mixed results to date and should be studied and improved. Health Aff (Millwood) 2013 0.87
44 Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes. J Am Geriatr Soc 2014 0.84
45 Value-based insurance design: embracing value over cost alone. Am J Manag Care 2009 0.83
46 Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. Am J Manag Care 2002 0.83
47 Effect of Medicare home health care payment on informal care. Inquiry 2009 0.83
48 A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci 2009 0.81
49 Cost of contraceptive methods to privately insured women in the United States. Womens Health Issues 2013 0.81
50 Two-year impact of the alternative quality contract on pediatric health care quality and spending. Pediatrics 2013 0.81
51 Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids. J Health Econ 2013 0.80
52 Drug plan design incentives among Medicare prescription drug plans. Am J Manag Care 2014 0.80
53 Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes. Health Aff (Millwood) 2013 0.80
54 Regulatory neutrality is essential to establishing a level playing field for accountable care organizations. Health Aff (Millwood) 2013 0.80
55 The relationship between health plan performance measures and physician network overlap: implications for measuring plan quality. Health Serv Res 2010 0.79
56 Medicare Part D plan generosity and medication use among dual-eligible nursing home residents. Med Care 2013 0.79
57 Potential consequences of reforming Medicare into a competitive bidding system. JAMA 2012 0.78
58 The effect of a large regional health plan's value-based insurance design program on statin use. Med Care 2012 0.78
59 Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis. Arthritis Rheum 2002 0.78
60 The effect of bundled payment on emergency department use: alternative quality contract effects after year one. Acad Emerg Med 2013 0.78
61 Price elasticity and medication use: cost sharing across multiple clinical conditions. J Manag Care Spec Pharm 2014 0.77
62 Treatment and cost implications of pertuzumab. Am J Manag Care 2012 0.77
63 Worker preferences, sorting and aggregate patterns of health insurance coverage. Int J Health Care Finance Econ 2007 0.77
64 Medicare supplemental coverage: the authors reply. Health Aff (Millwood) 2013 0.75
65 Confronting hysteria: a reply to Fairman and Curtiss. J Manag Care Pharm 2008 0.75
66 Supplemental coverage associated with more rapid spending growth for Medicare beneficiaries. Health Aff (Millwood) 2013 0.75
67 The cost-effectiveness of early noninvasive ventilation for ALS patients. BMC Health Serv Res 2005 0.75
68 High-risk medication use by nursing home residents before and after hospitalization. Med Care 2014 0.75
69 Performance in Year 1 of Pioneer Accountable Care Organizations. N Engl J Med 2015 0.75
70 Addressing the "chronification" of disease. Am J Manag Care 2017 0.75
71 Beneficial moral hazard and the theory of the second best. Inquiry 2009 0.75
72 The impact of the adoption of gag laws on trust in the patient-physician relationship. J Health Polit Policy Law 2007 0.75
73 Celebrating our 20th anniversary. Am J Manag Care 2015 0.75
74 "Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality. Am J Manag Care 2007 0.75
75 Provider behavior and treatment intensification in diabetes care. Am J Manag Care 2015 0.75
76 Taking stock at 2 years--continuing the journey. Am J Manag Care 2004 0.75
77 Insurers' competitive strategy and enrollment in newly offered preferred provider organizations (PPOs). Inquiry 2008 0.75
78 Value-based insurance design: benefits beyond cost and utilization. Am J Manag Care 2015 0.75
79 Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders. J Addict Med 2017 0.75
80 State-level impacts of Medicare Part D. Am J Manag Care 2011 0.75
81 The economics of resistant pathogens and antibiotic innovation. Am J Manag Care 2014 0.75
82 The challenges ahead for accountable care organizations (ACOs). Am J Manag Care 2011 0.75